TD Asset Management Inc raised its holdings in Docusign Inc. (NASDAQ:DOCU - Free Report) by 83.4% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 35,884 shares of the company's stock after purchasing an additional 16,314 shares during the period. TD Asset Management Inc's holdings in Docusign were worth $2,795,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of DOCU. GAMMA Investing LLC boosted its holdings in Docusign by 338.2% in the 1st quarter. GAMMA Investing LLC now owns 3,519 shares of the company's stock valued at $286,000 after purchasing an additional 2,716 shares during the period. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Docusign by 528.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 108,232 shares of the company's stock worth $8,810,000 after acquiring an additional 91,017 shares during the period. Janney Montgomery Scott LLC lifted its holdings in shares of Docusign by 6.6% during the 1st quarter. Janney Montgomery Scott LLC now owns 41,359 shares of the company's stock worth $3,367,000 after acquiring an additional 2,554 shares during the period. State of Alaska Department of Revenue increased its position in Docusign by 2.3% during the 1st quarter. State of Alaska Department of Revenue now owns 23,675 shares of the company's stock worth $1,927,000 after purchasing an additional 530 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. increased its position in Docusign by 23.9% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 4,132 shares of the company's stock worth $336,000 after purchasing an additional 798 shares in the last quarter. Institutional investors own 77.64% of the company's stock.
Insider Buying and Selling
In other news, CFO Blake Jeffrey Grayson sold 6,500 shares of the stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $71.20, for a total value of $462,800.00. Following the completion of the sale, the chief financial officer owned 105,660 shares in the company, valued at $7,522,992. This represents a 5.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider James P. Shaughnessy sold 7,500 shares of the stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $71.19, for a total transaction of $533,925.00. Following the completion of the sale, the insider owned 55,442 shares of the company's stock, valued at approximately $3,946,915.98. This represents a 11.92% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 102,533 shares of company stock valued at $7,709,933 over the last 90 days. 1.66% of the stock is currently owned by company insiders.
Docusign Trading Up 2.5%
Docusign stock opened at $72.44 on Wednesday. Docusign Inc. has a 1-year low of $66.35 and a 1-year high of $107.86. The firm has a market capitalization of $14.57 billion, a price-to-earnings ratio of 54.47, a price-to-earnings-growth ratio of 3.51 and a beta of 1.02. The firm's fifty day moving average price is $75.18 and its two-hundred day moving average price is $77.88.
Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The firm had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. During the same period last year, the firm earned $0.97 earnings per share. The business's quarterly revenue was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, research analysts forecast that Docusign Inc. will post 1.17 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of research firms recently issued reports on DOCU. Bank of America upped their price objective on shares of Docusign from $85.00 to $102.00 and gave the stock a "neutral" rating in a research report on Friday, September 5th. Royal Bank Of Canada upped their price objective on shares of Docusign from $90.00 to $95.00 and gave the company a "sector perform" rating in a research note on Friday, September 5th. Citigroup upped their price objective on shares of Docusign from $110.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, September 4th. Evercore ISI upped their price objective on shares of Docusign from $90.00 to $92.00 and gave the company an "in-line" rating in a research note on Friday, September 5th. Finally, Morgan Stanley raised their price target on shares of Docusign from $86.00 to $90.00 and gave the stock an "equal weight" rating in a report on Monday, September 8th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and fifteen have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $94.14.
Get Our Latest Analysis on DOCU
Docusign Company Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.